HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transduodenal sphincterotomy and type II Mirizzi syndrome].

Abstract
This paper describes the clinical course of a 76-year-old woman surgically treated in our department (General Surgery) for obstructive jaundice in Mirizzi syndrome (II). Ultrasonography and ERCP failed to demonstrate the pathological situation at the level of the biliary tree. When laparotomy was decided because of the progressive worsening of the general clinical conditions of the patient, intraoperative cholangiography showed the presence of a cholecystocholedochal fistula with multiple residual stones eroded into the common bile duct. Surgical management consisted of partial cholecystectomy, removal of the stones, choledochoplasty and exploration of the distal part of the common bile duct by a transduodenal sphincteroplasty. The post-operative period was uneventful and the patient was discharged from our department nine days after surgery. Even though the surgical approach to Mirizzi syndrome generally includes procedures other than papillosphincteroplasty+partial cholecystectomy, our experience seems to substantiate the efficacy of the previously mentioned treatment under suitable conditions.
AuthorsP Gorini, L Fogli, S Belcastro
JournalMinerva chirurgica (Minerva Chir) 1994 Jul-Aug Vol. 49 Issue 7-8 Pg. 729-31 ISSN: 0026-4733 [Print] Italy
Vernacular TitlePapillosfinteroplastica transduodenale e sindrome di Mirizzi di tipo II.
PMID7991183 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Biliary Fistula (complications, surgery)
  • Biliary Tract Surgical Procedures
  • Cholestasis (complications, surgery)
  • Common Bile Duct Diseases (complications, surgery)
  • Female
  • Gallbladder Diseases (complications, surgery)
  • Humans
  • Sphincterotomy, Transduodenal
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: